INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 151 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,775,000 | -13.8% | 1,714,727 | +10.5% | 0.00% | -25.0% |
Q3 2016 | $18,301,000 | -4.4% | 1,552,250 | +5.0% | 0.00% | 0.0% |
Q2 2016 | $19,135,000 | -20.2% | 1,478,755 | -1.3% | 0.00% | -33.3% |
Q1 2016 | $23,967,000 | -40.9% | 1,498,868 | +5.9% | 0.01% | -33.3% |
Q4 2015 | $40,535,000 | -10.2% | 1,415,828 | -10.7% | 0.01% | -25.0% |
Q3 2015 | $45,118,000 | -15.4% | 1,585,310 | +6.7% | 0.01% | -7.7% |
Q2 2015 | $53,353,000 | +28.0% | 1,485,339 | +107.1% | 0.01% | +30.0% |
Q1 2015 | $41,691,000 | +42.3% | 717,195 | +3.2% | 0.01% | +42.9% |
Q4 2014 | $29,305,000 | +14.5% | 695,087 | +5.3% | 0.01% | 0.0% |
Q3 2014 | $25,601,000 | +26.1% | 660,160 | +1.5% | 0.01% | +16.7% |
Q2 2014 | $20,310,000 | -18.9% | 650,326 | +7.6% | 0.01% | -14.3% |
Q1 2014 | $25,046,000 | +67.8% | 604,540 | +56.8% | 0.01% | +40.0% |
Q4 2013 | $14,923,000 | +194.2% | 385,516 | +166.0% | 0.01% | +150.0% |
Q3 2013 | $5,072,000 | +190.3% | 144,942 | +14.9% | 0.00% | +100.0% |
Q2 2013 | $1,747,000 | – | 126,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |